APO Research
Talk to an analyst

APO RESEARCH · REPORT

Constipation Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Constipation Treatment Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchConstipation Treatment Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Constipation Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Constipation Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Constipation Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Constipation Treatment Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Constipation Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Constipation Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Constipation Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Constipation Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Constipation Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Constipation Treatment include Abbott, Takeda, Sanofi, Bayer, AstraZeneca, Sucampo Pharmaceuticals, Shionogi, SGYP and Renexxion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Constipation Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Constipation Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Constipation Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Constipation Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Constipation Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Constipation Treatment revenue, projected growth trends, production technology, application and end-user industry.

Constipation Treatment Segment by Company

Abbott

Takeda

Sanofi

Bayer

AstraZeneca

Sucampo Pharmaceuticals

Shionogi

SGYP

Renexxion

Prestige Brands

Janssen Pharmaceutical

Ironwood Pharmaceuticals

Daewoong

Cosmo Pharmaceuticals

Albireo Pharma

Constipation Treatment Segment by Type

Opioid Induced Constipation

Irritable Bowel Syndrome with Constipation

Chronic Idiopathic Constipation

Constipation Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Constipation Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Constipation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Constipation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Constipation Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Constipation Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Constipation Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Constipation Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Constipation Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Opioid Induced Constipation Major Player Table 3. Irritable Bowel Syndrome with Constipation Major Player Table 4. Chronic Idiopathic Constipation Major Player Table 5. Global Constipation Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Player Table 7. Online Pharmacies Major Player Table 8. Retail Pharmacies Major Player Table 9. Constipation Treatment Industry Trends Table 10. Constipation Treatment Industry Drivers Table 11. Constipation Treatment Industry Opportunities and Challenges Table 12. Constipation Treatment Industry Restraints Table 13. Global Constipation Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Constipation Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Constipation Treatment Market Share by Region (2021-2026) Table 16. Global Constipation Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Constipation Treatment Market Share by Region (2027-2032) Table 18. Global Constipation Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Constipation Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Constipation Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Constipation Treatment Key Players Headquarters & Area Served Table 22. Global Constipation Treatment Players, Product Type & Application Table 23. Global Constipation Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Constipation Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Constipation Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Constipation Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Constipation Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Constipation Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Constipation Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Constipation Treatment Revenue Market Share by Application (2027-2032) Table 36. Abbott Company Information Table 37. Abbott Business Overview Table 38. Abbott Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott Constipation Treatment Product Portfolio Table 40. Abbott Recent Development Table 41. Takeda Company Information Table 42. Takeda Business Overview Table 43. Takeda Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Takeda Constipation Treatment Product Portfolio Table 45. Takeda Recent Development Table 46. Sanofi Company Information Table 47. Sanofi Business Overview Table 48. Sanofi Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Sanofi Constipation Treatment Product Portfolio Table 50. Sanofi Recent Development Table 51. Bayer Company Information Table 52. Bayer Business Overview Table 53. Bayer Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bayer Constipation Treatment Product Portfolio Table 55. Bayer Recent Development Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AstraZeneca Constipation Treatment Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Sucampo Pharmaceuticals Company Information Table 62. Sucampo Pharmaceuticals Business Overview Table 63. Sucampo Pharmaceuticals Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sucampo Pharmaceuticals Constipation Treatment Product Portfolio Table 65. Sucampo Pharmaceuticals Recent Development Table 66. Shionogi Company Information Table 67. Shionogi Business Overview Table 68. Shionogi Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Shionogi Constipation Treatment Product Portfolio Table 70. Shionogi Recent Development Table 71. SGYP Company Information Table 72. SGYP Business Overview Table 73. SGYP Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. SGYP Constipation Treatment Product Portfolio Table 75. SGYP Recent Development Table 76. Renexxion Company Information Table 77. Renexxion Business Overview Table 78. Renexxion Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Renexxion Constipation Treatment Product Portfolio Table 80. Renexxion Recent Development Table 81. Prestige Brands Company Information Table 82. Prestige Brands Business Overview Table 83. Prestige Brands Constipation Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Prestige Brands Constipation Treatment Product Portfolio Table 85. Prestige Brands Recent Development Table 86. Janssen Pharmaceutical Company Information Table 87. Janssen Pharmaceutical Business Overview Table 88. Janssen Pharmaceutical Constipation Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Janssen Pharmaceutical Constipation Treatment Product Portfolio Table 90. Janssen Pharmaceutical Recent Development Table 91. Ironwood Pharmaceuticals Company Information Table 92. Ironwood Pharmaceuticals Business Overview Table 93. Ironwood Pharmaceuticals Constipation Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Ironwood Pharmaceuticals Constipation Treatment Product Portfolio Table 95. Ironwood Pharmaceuticals Recent Development Table 96. Daewoong Company Information Table 97. Daewoong Business Overview Table 98. Daewoong Constipation Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Daewoong Constipation Treatment Product Portfolio Table 100. Daewoong Recent Development Table 101. Cosmo Pharmaceuticals Company Information Table 102. Cosmo Pharmaceuticals Business Overview Table 103. Cosmo Pharmaceuticals Constipation Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Cosmo Pharmaceuticals Constipation Treatment Product Portfolio Table 105. Cosmo Pharmaceuticals Recent Development Table 106. Albireo Pharma Company Information Table 107. Albireo Pharma Business Overview Table 108. Albireo Pharma Constipation Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Albireo Pharma Constipation Treatment Product Portfolio Table 110. Albireo Pharma Recent Development Table 111. North America Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Constipation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Constipation Treatment Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Constipation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Constipation Treatment Revenue by Country (US$ Million) & (2027-2032) Table 125. China Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 126. China Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 127. China Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 128. China Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Constipation Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Constipation Treatment Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Constipation Treatment Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Constipation Treatment Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Constipation Treatment Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Constipation Treatment Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Constipation Treatment Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Constipation Treatment Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Constipation Treatment Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Constipation Treatment Image Figure 2. Global Constipation Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Constipation Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Opioid Induced Constipation Image Figure 5. Irritable Bowel Syndrome with Constipation Image Figure 6. Chronic Idiopathic Constipation Image Figure 7. Global Constipation Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Constipation Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Constipation Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Constipation Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Constipation Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Constipation Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Constipation Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Constipation Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Constipation Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Constipation Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Constipation Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Constipation Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Constipation Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Constipation Treatment Revenue Share by Type (2021-2032) Figure 25. North America Constipation Treatment Revenue Share by Application (2021-2032) Figure 26. North America Constipation Treatment Revenue Share by Country (2021-2032) Figure 27. United States Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Constipation Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Constipation Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Constipation Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Constipation Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Constipation Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Constipation Treatment Revenue Share by Type (2021-2032) Figure 44. China Constipation Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Constipation Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Constipation Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Constipation Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Constipation Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Constipation Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Constipation Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Constipation Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Constipation Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Constipation Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Induced Constipation
  • Irritable Bowel Syndrome with Constipation
  • Chronic Idiopathic Constipation
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Abbott
  • Takeda
  • Sanofi
  • Bayer
  • AstraZeneca
  • Sucampo Pharmaceuticals
  • Shionogi
  • SGYP
  • Renexxion
  • Prestige Brands
  • Janssen Pharmaceutical
  • Ironwood Pharmaceuticals
  • Daewoong
  • Cosmo Pharmaceuticals
  • Albireo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Constipation Treatment Market by Type
  3. 1.2.1 Global Constipation Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Opioid Induced Constipation
  5. 1.2.3 Irritable Bowel Syndrome with Constipation
  6. 1.2.4 Chronic Idiopathic Constipation
  7. 1.3 Constipation Treatment Market by Application
  8. 1.3.1 Global Constipation Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Constipation Treatment Market Dynamics
  1. 2.1 Constipation Treatment Industry Trends
  2. 2.2 Constipation Treatment Industry Drivers
  3. 2.3 Constipation Treatment Industry Opportunities and Challenges
  4. 2.4 Constipation Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Constipation Treatment Market Perspective (2021-2032)
  2. 3.2 Global Constipation Treatment Growth Trends by Region
  3. 3.2.1 Global Constipation Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Constipation Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Constipation Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Constipation Treatment Revenue by Players
  2. 4.1.1 Global Constipation Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Constipation Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Constipation Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Constipation Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Constipation Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Constipation Treatment Players, Product Type & Application
  8. 4.5 Global Constipation Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Constipation Treatment Market CR5 and HHI
  11. 4.6.3 2025 Constipation Treatment Tier 1, Tier 2, and Tier 3
5 Constipation Treatment Market Size by Type
  1. 5.1 Global Constipation Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Constipation Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Constipation Treatment Revenue Market Share by Type (2021-2032)
6 Constipation Treatment Market Size by Application
  1. 6.1 Global Constipation Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Constipation Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Constipation Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Constipation Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Constipation Treatment Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Constipation Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Constipation Treatment Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Constipation Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Constipation Treatment Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Constipation Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Constipation Treatment Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Constipation Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Constipation Treatment Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Sucampo Pharmaceuticals
  32. 7.6.1 Sucampo Pharmaceuticals Company Information
  33. 7.6.2 Sucampo Pharmaceuticals Business Overview
  34. 7.6.3 Sucampo Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sucampo Pharmaceuticals Constipation Treatment Product Portfolio
  36. 7.6.5 Sucampo Pharmaceuticals Recent Developments
  37. 7.7 Shionogi
  38. 7.7.1 Shionogi Company Information
  39. 7.7.2 Shionogi Business Overview
  40. 7.7.3 Shionogi Constipation Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shionogi Constipation Treatment Product Portfolio
  42. 7.7.5 Shionogi Recent Developments
  43. 7.8 SGYP
  44. 7.8.1 SGYP Company Information
  45. 7.8.2 SGYP Business Overview
  46. 7.8.3 SGYP Constipation Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SGYP Constipation Treatment Product Portfolio
  48. 7.8.5 SGYP Recent Developments
  49. 7.9 Renexxion
  50. 7.9.1 Renexxion Company Information
  51. 7.9.2 Renexxion Business Overview
  52. 7.9.3 Renexxion Constipation Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Renexxion Constipation Treatment Product Portfolio
  54. 7.9.5 Renexxion Recent Developments
  55. 7.10 Prestige Brands
  56. 7.10.1 Prestige Brands Company Information
  57. 7.10.2 Prestige Brands Business Overview
  58. 7.10.3 Prestige Brands Constipation Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Prestige Brands Constipation Treatment Product Portfolio
  60. 7.10.5 Prestige Brands Recent Developments
  61. 7.11 Janssen Pharmaceutical
  62. 7.11.1 Janssen Pharmaceutical Company Information
  63. 7.11.2 Janssen Pharmaceutical Business Overview
  64. 7.11.3 Janssen Pharmaceutical Constipation Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Janssen Pharmaceutical Constipation Treatment Product Portfolio
  66. 7.11.5 Janssen Pharmaceutical Recent Developments
  67. 7.12 Ironwood Pharmaceuticals
  68. 7.12.1 Ironwood Pharmaceuticals Company Information
  69. 7.12.2 Ironwood Pharmaceuticals Business Overview
  70. 7.12.3 Ironwood Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Ironwood Pharmaceuticals Constipation Treatment Product Portfolio
  72. 7.12.5 Ironwood Pharmaceuticals Recent Developments
  73. 7.13 Daewoong
  74. 7.13.1 Daewoong Company Information
  75. 7.13.2 Daewoong Business Overview
  76. 7.13.3 Daewoong Constipation Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Daewoong Constipation Treatment Product Portfolio
  78. 7.13.5 Daewoong Recent Developments
  79. 7.14 Cosmo Pharmaceuticals
  80. 7.14.1 Cosmo Pharmaceuticals Company Information
  81. 7.14.2 Cosmo Pharmaceuticals Business Overview
  82. 7.14.3 Cosmo Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cosmo Pharmaceuticals Constipation Treatment Product Portfolio
  84. 7.14.5 Cosmo Pharmaceuticals Recent Developments
  85. 7.15 Albireo Pharma
  86. 7.15.1 Albireo Pharma Company Information
  87. 7.15.2 Albireo Pharma Business Overview
  88. 7.15.3 Albireo Pharma Constipation Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Albireo Pharma Constipation Treatment Product Portfolio
  90. 7.15.5 Albireo Pharma Recent Developments
8 North America
  1. 8.1 North America Constipation Treatment Revenue (2021-2032)
  2. 8.2 North America Constipation Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Constipation Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Constipation Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Constipation Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Constipation Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Constipation Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Constipation Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Constipation Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Constipation Treatment Revenue by Country
  11. 8.6.1 North America Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Constipation Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Constipation Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Constipation Treatment Revenue (2021-2032)
  2. 9.2 Europe Constipation Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Constipation Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Constipation Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Constipation Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Constipation Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Constipation Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Constipation Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Constipation Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Constipation Treatment Revenue by Country
  11. 9.6.1 Europe Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Constipation Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Constipation Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Constipation Treatment Revenue (2021-2032)
  2. 10.2 China Constipation Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Constipation Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Constipation Treatment Revenue by Type (2027-2032)
  5. 10.3 China Constipation Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Constipation Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Constipation Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Constipation Treatment Revenue by Application (2027-2032)
  9. 10.5 China Constipation Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Constipation Treatment Revenue (2021-2032)
  2. 11.2 Asia Constipation Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Constipation Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Constipation Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Constipation Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Constipation Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Constipation Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Constipation Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Constipation Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Constipation Treatment Revenue by Country
  11. 11.6.1 Asia Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Constipation Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Constipation Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Constipation Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Constipation Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Constipation Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Constipation Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Constipation Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Constipation Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Constipation Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Constipation Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Constipation Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Constipation Treatment Revenue by Country
  11. 12.6.1 SAMEA Constipation Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Constipation Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Constipation Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst